Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment.
Schirizzi A, Arshadi A, Tolomeo D, Schirosi L, Valentini AM, De Leonardis G, Refolo MG, Donghia R, Storlazzi CT, Zito A, Ricci AD, Vallarelli S, Ostuni C, Bencivenga M, De Manzoni G, Messa C, Armentano R, Giannelli G, Lotesoriere C, D'Alessandro R. Schirizzi A, et al. Among authors: de leonardis g. Biomedicines. 2023 Oct 7;11(10):2721. doi: 10.3390/biomedicines11102721. Biomedicines. 2023. PMID: 37893095 Free PMC article.
Variations in Circulating Levels of Angiopoietin-2 Over Time Are Predictive of Ramucirumab-Paclitaxel Therapy Outcome in Advanced Gastric Cancer: Results of Prospective Study.
D'Alessandro R, Refolo MG, Schirizzi A, De Leonardis G, Donghia R, Guerra V, Giannelli G, Lolli IR, Laterza MM, De Vita F, Messa C, Lotesoriere C. D'Alessandro R, et al. Among authors: de leonardis g. Front Oncol. 2022 Apr 6;12:862116. doi: 10.3389/fonc.2022.862116. eCollection 2022. Front Oncol. 2022. PMID: 35463372 Free PMC article.
The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines.
Schirizzi A, Contino M, Carrieri L, Riganti C, De Leonardis G, Scavo MP, Perrone MG, Miciaccia M, Kopecka J, Refolo MG, Lotesoriere C, Depalo N, Rizzi F, Giannelli G, Messa C, D'Alessandro R. Schirizzi A, et al. Among authors: de leonardis g. Front Oncol. 2023 Feb 16;13:1129832. doi: 10.3389/fonc.2023.1129832. eCollection 2023. Front Oncol. 2023. PMID: 36874116 Free PMC article.
Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab-paclitaxel therapy outcome in advanced gastric cancer: results of prospective study.
D'Alessandro R, Refolo MG, Schirizzi A, De Leonardis G, Donghia R, Guerra V, Giannelli G, Lolli IR, Laterza MM, De Vita F, Messa C, Lotesoriere C. D'Alessandro R, et al. Among authors: de leonardis g. Front Oncol. 2023 Apr 14;13:1187014. doi: 10.3389/fonc.2023.1187014. eCollection 2023. Front Oncol. 2023. PMID: 37124498 Free PMC article.
Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues.
Schirizzi A, De Leonardis G, Lorusso V, Donghia R, Rizzo A, Vallarelli S, Ostuni C, Troiani L, Lolli IR, Giannelli G, Ricci AD, D'Alessandro R, Lotesoriere C. Schirizzi A, et al. Among authors: de leonardis g. Cancers (Basel). 2023 Apr 19;15(8):2376. doi: 10.3390/cancers15082376. Cancers (Basel). 2023. PMID: 37190304 Free PMC article. Review.
Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models.
Francavilla F, Sarcina F, Schepetkin IA, Kirpotina LN, Contino M, Schirizzi A, De Leonardis G, Khlebnikov AI, D'Alessandro R, Quinn MT, Lacivita E, Leopoldo M. Francavilla F, et al. Among authors: de leonardis g. Eur J Med Chem. 2023 Dec 5;261:115854. doi: 10.1016/j.ejmech.2023.115854. Epub 2023 Oct 4. Eur J Med Chem. 2023. PMID: 37839346 Free article.
Fatty liver and mortality: a cohort population study in South Italy.
Caruso MG, Veronese N, Notarnicola M, Cisternino AM, Reddavide R, Inguaggiato R, Guerra V, Donghia R, Logroscino A, Rotolo O, Chiloiro M, Leandro G, De Leonardis G, Tutino V, Misciagna G, Bonfiglio C, Guerra R, Osella A. Caruso MG, et al. Among authors: de leonardis g. BMJ Open. 2019 Jun 20;9(6):e027379. doi: 10.1136/bmjopen-2018-027379. BMJ Open. 2019. PMID: 31227533 Free PMC article.
Aerobic Physical Activity and a Low Glycemic Diet Reduce the AA/EPA Ratio in Red Blood Cell Membranes of Patients with NAFLD.
Tutino V, De Nunzio V, Caruso MG, Bonfiglio C, Franco I, Mirizzi A, De Leonardis G, Cozzolongo R, Giannuzzi V, Giannelli G, Notarnicola M, Osella AR. Tutino V, et al. Among authors: de nunzio v, de leonardis g. Nutrients. 2018 Sep 13;10(9):1299. doi: 10.3390/nu10091299. Nutrients. 2018. PMID: 30217048 Free PMC article. Clinical Trial.
Women in LOVe: Lacto-Ovo-Vegetarian Diet Rich in Omega-3 Improves Vasomotor Symptoms in Postmenopausal Women. An Exploratory Randomized Controlled Trial.
Rotolo O, Zinzi I, Veronese N, Cisternino AM, Reddavide R, Inguaggiato R, Leandro G, Notarnicola M, Tutino V, De Nunzio V, De Leonardis G, Guerra V, Donghia R, Fucilli F, Licinio R, Mastrosimini A, Rinaldi CCM, Daddabbo T, Giampaolo N, Iacovazzi PA, Giannico S, Caruso MG. Rotolo O, et al. Among authors: de leonardis g. Endocr Metab Immune Disord Drug Targets. 2019;19(8):1232-1239. doi: 10.2174/1871530319666190528101532. Endocr Metab Immune Disord Drug Targets. 2019. PMID: 31132980 Clinical Trial.
15 results